carvedilol has been researched along with thapsigargin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jan, CR; Liu, CP | 1 |
| Li, R; Liu, XY; Qian, YR; Yi, QJ | 1 |
2 other study(ies) available for carvedilol and thapsigargin
| Article | Year |
|---|---|
Effect of carvedilol on Ca2+ movement and cytotoxicity in human MG63 osteosarcoma cells.
Topics: Adenylyl Cyclases; Calcium; Calcium Channels; Calcium Signaling; Carbazoles; Carvedilol; Cell Compartmentation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colforsin; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Estrenes; Fluorescence; Fura-2; Histamine; Histamine Antagonists; Humans; Inositol 1,4,5-Trisphosphate; Manganese; Osteosarcoma; Phorbol Esters; Propanolamines; Protein Kinase C; Pyrrolidinones; Tetrazolium Salts; Thapsigargin; Time Factors; Type C Phospholipases | 2004 |
[Effect of carvedilol on ryanodine receptor in heart failure].
Topics: Adrenergic beta-Antagonists; Animals; Animals, Newborn; Calcium; Calcium Signaling; Calcium-Transporting ATPases; Carbazoles; Carvedilol; Disease Models, Animal; Heart Failure; Myocardial Contraction; Myocytes, Cardiac; Propanolamines; Rats; Rats, Wistar; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Spectrometry, Fluorescence; Thapsigargin; Ultrasonography | 2005 |